Biotech & pharma
Genetic mutations warn of skin cancer risk
21 Apr 2014
Gene variant raises risk for aortic tear and rupture
By By Helen Dodson | 19 Apr 2014
Stanford researchers develop a single-cell genomics technique to reverse engineer the developing lung
By By Tom Abate | Stanford Engineering | 17 Apr 2014
Limiting certain protein in the brain reverses Alzheimer's symptoms
By By Deborah Halber | 16 Apr 2014
New finding suggests a way to block stress’ damage
By By Bill Hathaway | 14 Apr 2014
Biomolecular tweezers facilitate study of mechanical force effects on cells and proteins
12 Apr 2014
Genetic mutations warn of skin cancer risk
07 Apr 2014
Battling infection with microbes
04 Apr 2014
A key link between tumours and healthy tissue identified
By By Bill Hathaway | 22 Mar 2014
Researchers slow pancreatic cancer growth and spread by blocking key enzyme
By By Francesca Davenport | 18 Mar 2014
Exploring how cancerous and healthy cells compete may help us understand cancer
By By Gail Wilson | 11 Mar 2014
UV light aids cancer cells that creep along the outside of blood vessels
By By Shaun Mason | 11 Mar 2014
A changing view of bone marrow cells
08 Mar 2014
Lab-grown human heart cells could mean fewer animals used in research
By By Sam Wong | 06 Mar 2014
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
